Tvardi Therapeutics Inc (TVRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 23,003 | 4,790 | 821 | 20,272 | 0 |
| Cost of Goods | N/A | 2,081 | N/A | N/A | N/A |
| Gross Profit | 23,003 | 2,709 | 821 | 20,272 | N/A |
| Operating Expenses | 27,475 | 30,701 | 34,343 | 21,396 | 30,876 |
| Operating Income | -4,472 | -27,911 | -33,522 | -1,124 | -30,876 |
| Other Income | 266 | 162 | 140 | 111 | 131 |
| Pre-tax Income | -4,206 | -27,749 | -33,382 | -1,013 | -30,745 |
| Net Income Continuous | -4,206 | -27,749 | -33,382 | -1,013 | -30,745 |
| Net Income | $-4,206 | $-27,749 | $-33,382 | $-1,013 | $-30,745 |
| EPS Basic Total Ops | -2.88 | -18.73 | -23.05 | -0.72 | -21.97 |
| EPS Basic Continuous Ops | -2.83 | -18.68 | -23.14 | -0.73 | -22.12 |
| EPS Diluted Total Ops | -2.88 | -18.73 | -23.05 | -0.72 | -21.97 |
| EPS Diluted Continuous Ops | -2.83 | -18.68 | -23.14 | -0.73 | -22.12 |
| EBITDA(a) | $-3,820 | $-27,212 | $-32,852 | $-525 | $-30,303 |